OTC, supplements & other. Every registered pack in the UAE with published prices, agents and manufacturers; the price spread between brands; the same medicine in India, the US and the EU; and same‑class alternatives.
Unit price to public, same form and strength, registered brands only. Green = cheapest. The spread is the gap a class‑level tender or formulary switch can usually close.
India: India brand MRP (median of 2) ₹4.21 ($0.050) per tablet at 150mg. US prices are not published by FDA; EU prices are national. Ask us for a landed‑cost benchmark.
₹2.85–14.82 per unit across 4 priced packs. MRP as printed on pack (indicative, open dataset 2024); combinations listed after single‑ingredient brands. Showing 4 of 4.
| Brand | Manufacturer | Strength | Pack | MRP ₹ | ₹ / unit |
|---|---|---|---|---|---|
| Cervas 150mg Tablet | Mano Pharma Pvt Ltd | 150mg | strip of 10 tablets | ₹28.50 | ₹2.85 |
| Complamina Tablet | Zydus Cadila | 150mg | strip of 10 tablets | ₹42.05 | ₹4.21 |
| Complamina 300mg Injection | Zydus Cadila | 300mg | ampoule of 2 ml Injection | ₹25.24 | ₹12.62 |
| Complamina Retard 500 Tablet SR | Zydus Cadila | 500mg | strip of 10 tablet sr | ₹148.22 | ₹14.82 |
Not yet classified.
None are Active on the UAE register at this release.
No published UAE price at this release.
No matching‑strength India reference price is available for a per‑unit comparison.
See the register tab.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Data: DoH Abu Dhabi Shafafiya drug list (2 Nov 2026); FDA NDC Directory and Orange Book (Sept–Nov 2026); NPPA and PMBI Jan Aushadhi (Nov 2026); EMA (Nov 2026); WHO ATC/DDD 2026; Consulting Wallah class repository. For information only; verify with the regulator before purchase or dispensing. No prescribing advice. © Consulting Wallah — CC BY‑NC‑ND; bulk extraction not permitted.